Sever Asthmatic patients with OCS
Oral corticosteroids, the double-edged sword of severe Asthma. Even one or two courses of oral corticosteroids over the year increase risk of patients' systemic adverse events. Unfortunately, 93% of Patients With Severe Asthma have at least One Condition Related to OCS Use1*
References
- Price DB, et all Asthma Ahergy.2018; II: 193204.
- Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. Updated 2023. Accessed 22 September 2023. https://ginasthma.org/ginæports/.
- Volmer T, et aleur Respir 1800703.
- Sames E, et ailin Ther.2011;33(IO):14131432)
MAT-BH-2400426/V1/DEC 2024